High-Dose Vitamin B3 Shows Promise Against Deadly Brain Cancer Glioblastoma
A clinical trial is investigating whether high doses of vitamin B3 (niacin) can improve survival for patients with glioblastoma, one of the deadliest brain cancers. Researchers found that niacin may reactivate immune cells suppressed by tumors, enabling them to attack cancer more effectively. Early results show patients experiencing significantly better progression-free survival than typically expected with this aggressive disease.
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!